Understanding aneuploidy tolerance in cancer by studying early embryogenesis

Informazioni relative al progetto

OncoFetal_Ploidy

ID dell’accordo di sovvenzione: 101068843

DOI

10.3030/101068843

Progetto chiuso

Data della firma CE 14 Luglio 2022

Data di avvio 1 Luglio 2022

Data di completamento 30 Novembre 2024

Finanziato da

• Marie Skłodowska-Curie Actions (MSCA)

Costo totale

Nessun dato

Contributo UE

€ 190 374,32

Coordinato da

STICHTING HET NEDERLANDS KANKER INSTITUUT-ANTONI VAN LEEUWENHOEK ZIEKENHUIS
Netherlands

Periodic Reporting for period 1 - OncoFetal_Ploidy (Understanding aneuploidy tolerance in cancer by studying early embryogenesis)

Periodo di rendicontazione: 2022-07-01 al 2024-11-30

Sintesi del contesto e degli obiettivi generali del progetto

What is Aneuploidy?

Every human cell contains DNA that is packed into 46 chromosomes. Imagine these 46 chromosomes as instruction manuals in a library that help the cell operate its functions. Within the human body cells divide everyday. During cell divisions, errors can occur, and daughter cells can end up with extra or missing chromosomes - a condition called aneuploidy.

If chromosomes are like instruction manuals for the cells, missing a copy of a manual means losing crucial information, while an extra copy creates confusion about which version to use. Therefore, one might assume aneuploidy is always detrimental to the cell, however, it turns out it depends on a context.

What makes some cells tolerant to aneuploidy?

In the body cells can have different levels of specializations. “Specialized” cells perform specific tasks, for example red blood cells carry oxygen, muscle cells contract, nerve cells carry electrical impulses. “Unspecialized” cells haven’t been assigned a role yet—they can turn into different types of cells depending on what your body needs. Do those different types of cell specializations influence tolerance of aneuploidy? If yes, what are the mechanisms?

Why study aneuploidy?

Aneuploid cancer cells tend to be more resistant to the treatment, more prone to spread to other parts of the body, and aneuploid cancers tend to be associated with poorer prognosis for the patient. Understanding what allows cancer cells to tolerate a high degree of aneuploidy would allow us to understand the disease better, take actions to target those mechanisms, ultimately making the disease more manageable.

Lavoro eseguito dall’inizio del progetto fino alla fine del periodo coperto dalla relazione e principali risultati finora ottenuti

How did the project move us closer to the answer?

Firstly, the project focused on building an experimental platform to study the question of how specialized and unspecialized cells deal with aneuploidy.

This means, choosing the best cells to study. Growing and genetically engineering cells so that they express colored proteins when they become specialized or unspecialized to help researchers distinguish between them. Optimising protocols to allow cells the optimal conditions to grow and divide happily under the microscope for several days, and to acquire high quality data at the same time.

Having gathered all of the information above the project was able to validate that the hypothesis was indeed correct – the cells deal differently with aneuploidy depending on how specialized they are. The unspecialized cells are more prone to making mistakes and tolerating them. The experiments are currently ongoing to understand why that is, and what sets unspecialized and specialized cells apart in that regard.

Progressi oltre lo stato dell’arte e potenziale impatto previsto (incluso l’impatto socioeconomico e le implicazioni sociali più ampie del progetto fino ad ora)

The study not only deepens scientific insight into the cellular aspects that influence aneuploidy occurrence and tolerance, it also paves the way for potential future advancements in cancer treatment.

Colon organoid with differently colored cells depending on their specialization